Explore

AP News AP News
Judge approves OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves

Judge approves OxyContin maker Purdue Pharma's criminal sentence, a last step before it dissolves

OxyContin maker Purdue Pharma has been ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller
AP News AP News
OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence

OxyContin maker Purdue Pharma has been ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller
Rapid Read Rapid Read
Federal Judge to Order Purdue Pharma to Forfeit $225 Million in Justice Department Case

Federal Judge to Order Purdue Pharma to Forfeit $225 Million in Justice Department Case

A federal judge is set to conduct a sentencing hearing for Purdue Pharma, where the company is expected to be ordered to forfeit $225 million to the Justice Department. This development is part of a broader legal case involving Purdue Pharma, which has been under scrutiny for its role in the opioid crisis. The company has faced numerous lawsuits and legal challenges over the years, primarily due to its marketing practices related to OxyContin, a powerful opioid painkiller. The forfeiture is part of a settlement agreement aimed at addressing the company's alleged misconduct and its impact on public health.
Rapid Read Rapid Read
Purdue Pharma Sentenced in Opioid Case, Sackler Family Avoids Charges

Purdue Pharma Sentenced in Opioid Case, Sackler Family Avoids Charges

Purdue Pharma has been sentenced to pay $225 million in fines to the U.S. Justice Department as part of a criminal settlement related to its role in the opioid crisis. The company admitted to misleading the public about the safety of OxyContin and engaging in illegal marketing practices. Despite the settlement, members of the Sackler family, who own Purdue Pharma, will not face criminal charges. The settlement follows years of legal battles over the company's bankruptcy and its role in the opioid epidemic, which has claimed hundreds of thousands of lives in the U.S.
Rapid Read Rapid Read
Judge Approves Sentence for OxyContin Maker Purdue Pharma in Newark

Judge Approves Sentence for OxyContin Maker Purdue Pharma in Newark

A judge in Newark has approved a criminal sentence for Purdue Pharma, the maker of OxyContin. This decision is part of ongoing legal proceedings against the company, which has faced significant scrutiny and legal challenges due to its role in the opioid crisis. Purdue Pharma has been accused of contributing to widespread addiction and overdose deaths through its aggressive marketing of OxyContin. The sentencing marks a significant development in the legal battles surrounding the company, which has been under intense public and legal pressure to account for its actions.
Rapid Read Rapid Read
Judge Approves Sentence for Purdue Pharma in OxyContin Case

Judge Approves Sentence for Purdue Pharma in OxyContin Case

A judge in Newark has approved a criminal sentence for Purdue Pharma, the manufacturer of OxyContin. This decision marks a significant development in the legal proceedings against the company, which has been at the center of the opioid crisis in the United States. Purdue Pharma has faced numerous lawsuits and legal challenges over its role in the widespread addiction and overdose deaths linked to its painkiller, OxyContin. The sentencing is part of a broader effort to hold pharmaceutical companies accountable for their contributions to the opioid epidemic, which has claimed hundreds of thousands of lives across the country.
Rapid Read Rapid Read
Natural Disasters Threaten Opioid Recovery Efforts in the U.S.

Natural Disasters Threaten Opioid Recovery Efforts in the U.S.

Natural disasters, such as Hurricane Helene in 2024, have exacerbated challenges for individuals recovering from opioid addiction by disrupting access to essential medications like Suboxone. The storm's impact in North Carolina highlighted the vulnerability of recovery efforts during emergencies, as patients struggled to obtain prescriptions due to infrastructure damage. A group of doctors is advocating for policy changes to ensure better access to addiction medications during such crises, emphasizing the need for federal and state governments to address these gaps as climate change increases the frequency of severe weather events.
Rapid Read Rapid Read
RFK Jr.'s Wellness Farm Proposal Sparks Debate Over Addiction Treatment

RFK Jr.'s Wellness Farm Proposal Sparks Debate Over Addiction Treatment

U.S. Health Secretary Robert Kennedy Jr. has faced scrutiny over his proposal to establish 'wellness farms' for addiction recovery, inspired by the San Patrignano community in Italy. During a Senate hearing, Kennedy was questioned about his comments on 'reparenting' children on these farms, a concept he previously discussed in podcast interviews. The proposal involves creating rural farm camps to help individuals recover from addiction through work and community living, without the use of medication. Critics argue that this approach ignores scientifically proven treatments for addiction, such as medication-assisted therapy.
Rapid Read Rapid Read
Supreme Court Hears Monsanto v. Durnell on Pesticide Liability

Supreme Court Hears Monsanto v. Durnell on Pesticide Liability

The U.S. Supreme Court is currently hearing arguments in the case of Monsanto v. Durnell, which could have significant implications for pesticide manufacturers' liability. The case centers on whether companies like Monsanto can be held legally responsible for not warning the public about the health risks associated with their products, specifically glyphosate, the active ingredient in Roundup. The Center for Food Safety (CFS) is a key party in the case, advocating for stronger public health protections and transparency regarding pesticide risks. This case follows a 2022 federal court ruling that struck down the EPA's cancer safety determination for glyphosate as inconsistent with scientific standards.
Reuters Reuters
Purdue Pharma to be sentenced, paving way for opioid settlement

Purdue Pharma to be sentenced, paving way for opioid settlement

By Dietrich Knauth NEW YORK, April 28 (Reuters) - Purdue Pharma will be sentenced on Tuesday in New Jersey federal court for deceiving government regulators and paying kickbacks to doctors to boost opioid sales, completing a plea deal that clears the way for the company to dissolve in bankruptcy and
AP News AP News
OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves

OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves

OxyContin maker Purdue Pharma is expected to be ordered to pay $225 million in a criminal case related to how it sold its blockbuster opioid painkiller
Reuters Reuters
With Bayer at US Supreme Court, MAHA rallies against pesticides

With Bayer at US Supreme Court, MAHA rallies against pesticides

By Leah Douglas WASHINGTON, April 27 (Reuters) - "Make America Healthy Again" activists rallied at the U.S. Supreme Court building on Monday against Bayer as the justices heard arguments in the German company's effort to end thousands of lawsuits that allege its weedkiller Roundup causes cancer.